000 | 01917 a2200529 4500 | ||
---|---|---|---|
005 | 20250515080149.0 | ||
264 | 0 | _c20070925 | |
008 | 200709s 0 0 eng d | ||
022 | _a1471-2407 | ||
024 | 7 |
_a10.1186/1471-2407-7-155 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMelichar, Bohuslav | |
245 | 0 | 0 |
_aGastrointestinal permeability in ovarian cancer and breast cancer patients treated with paclitaxel and platinum. _h[electronic resource] |
260 |
_bBMC cancer _cAug 2007 |
||
300 |
_a155 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAdenocarcinoma _xdrug therapy |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aCarboplatin _xadministration & dosage |
650 | 0 | 4 |
_aCell Membrane Permeability _xdrug effects |
650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGastrointestinal Tract _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIntestinal Absorption _xdrug effects |
650 | 0 | 4 |
_aLactulose _xmetabolism |
650 | 0 | 4 |
_aMannitol _xmetabolism |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNeoplasms, Glandular and Epithelial _xdrug therapy |
650 | 0 | 4 |
_aOvarian Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
650 | 0 | 4 |
_aSucrose _xmetabolism |
650 | 0 | 4 | _aTrastuzumab |
650 | 0 | 4 |
_aXylose _xmetabolism |
700 | 1 | _aHyspler, Radomír | |
700 | 1 | _aDragounová, Emanuela | |
700 | 1 | _aDvorák, Josef | |
700 | 1 | _aKalábová, Hana | |
700 | 1 | _aTichá, Alena | |
773 | 0 |
_tBMC cancer _gvol. 7 _gp. 155 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1186/1471-2407-7-155 _zAvailable from publisher's website |
999 |
_c17220536 _d17220536 |